Crowley, Fionnuala http://orcid.org/0000-0001-9101-3912
Park, Wungki http://orcid.org/0000-0002-8006-3102
O’Reilly, Eileen M. http://orcid.org/0000-0002-8076-9199
Article History
Received: 8 May 2021
Accepted: 30 July 2021
First Online: 17 August 2021
Declarations
:
: FC: No conflicts of interest to declare.WP: Research funding to institution: Merck, Astellas, Gossamerbio.EOR: Research funding to MSK: Genentech/Roche, Celgene/BMS, BioNTech, BioAtla, AstraZeneca, Arcus, Elicio. Consulting Role: Cytomx Therapeutics (DSMB), Rafael Therapeutics (DSMB), Sobi, Silenseed, Molecular Templates, Boehringer Ingelheim, BioNTech, Ipsen, Polaris, Tyme, Seagen, Merck, AstraZeneca, Noxxon, BioSapien, Bayer (spouse), Genentech-Roche (spouse), Celgene-BMS (spouse), Eisai (spouse).